Literature DB >> 18843652

Combination contraceptives: effects on weight.

Maria F Gallo1, Laureen M Lopez, David A Grimes, Kenneth F Schulz, Frans M Helmerhorst.   

Abstract

BACKGROUND: Weight gain is often considered a side effect of combination hormonal contraceptives, and many women and clinicians believe that an association exists. Concern about weight gain can limit the use of this highly effective method of contraception by deterring the initiation of its use and causing early discontinuation among users. However, a causal relationship between combination contraceptives and weight gain has not been established.
OBJECTIVES: The aim of the review was to evaluate the potential association between combination contraceptive use and changes in weight. SEARCH STRATEGY: We searched the computerized databases MEDLINE, POPLINE, CENTRAL, EMBASE, and LILACS for studies of combination contraceptives, as well as clinical trials databases. We also wrote to known investigators and manufacturers to request information about other published or unpublished trials not discovered in our search. SELECTION CRITERIA: All English-language, randomized controlled trials were eligible if they had at least three treatment cycles and compared a combination contraceptive to a placebo or to a combination contraceptive that differed in drug, dosage, regimen, or study length. DATA COLLECTION AND ANALYSIS: All titles and abstracts located in the literature searches were assessed. Data were entered and analyzed with RevMan, and a second author verified the data entered. Depending on the data available, the mean difference using a fixed effects model with 95% confidence interval (CI) was calculated for the mean change in weight between baseline and post-treatment measurements or the Peto odds ratio with 95% confidence interval was calculated using the proportion of women who gained or lost more than a specified amount of weight. MAIN
RESULTS: The three placebo-controlled, randomized trials did not find evidence supporting a causal association between combination oral contraceptives or a combination skin patch and weight gain. Most comparisons of different combination contraceptives showed no substantial difference in weight. In addition, discontinuation of combination contraceptives because of weight gain did not differ between groups where this was studied. AUTHORS'
CONCLUSIONS: Available evidence was insufficient to determine the effect of combination contraceptives on weight, but no large effect was evident.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843652     DOI: 10.1002/14651858.CD003987.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

Review 1.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen-Mok; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

2.  Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.

Authors:  Paulina A Essah; James A Arrowood; Kai I Cheang; Swati S Adawadkar; Dale W Stovall; John E Nestler
Journal:  Fertil Steril       Date:  2011-07-05       Impact factor: 7.329

3.  Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.

Authors:  Mags E Beksinska; Jenni A Smit; Immo Kleinschmidt; Cecilia Milford; Timothy M M Farley
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

4.  Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

Authors:  Diana Mansour; Carole Verhoeven; Werner Sommer; Edith Weisberg; Surasak Taneepanichskul; Gian Benedetto Melis; Inger Sundström-Poromaa; Tjeerd Korver
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-10-13       Impact factor: 1.848

5.  Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.

Authors:  Richard S Legro; Silva A Arslanian; David A Ehrmann; Kathleen M Hoeger; M Hassan Murad; Renato Pasquali; Corrine K Welt
Journal:  J Clin Endocrinol Metab       Date:  2013-10-22       Impact factor: 5.958

6.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.